![]() |
Volumn 19, Issue 9, 2002, Pages 752-757
|
Gliclazide improves anti-oxidant status and nitric oxide-mediated vasodilation in Type 2 diabetes
|
Author keywords
Anti oxidant status; Gliclazide; Type 2 diabetes mellitus; Vascular function
|
Indexed keywords
ARGININE;
GLIBENCLAMIDE;
GLICLAZIDE;
LIPID PEROXIDE;
NITRIC OXIDE;
ADULT;
AGED;
ANTIOXIDANT ACTIVITY;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIASTOLIC BLOOD PRESSURE;
DRUG EFFECT;
DRUG EFFICACY;
HUMAN;
LIPID BLOOD LEVEL;
MALE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OXIDATIVE STRESS;
RANDOMIZED CONTROLLED TRIAL;
SYSTOLIC BLOOD PRESSURE;
TREATMENT OUTCOME;
VASODILATATION;
ADULT;
AGED;
ANTIOXIDANTS;
ARGININE;
BLOOD PRESSURE;
DIABETES MELLITUS, TYPE 2;
FREE RADICALS;
GLICLAZIDE;
GLYBURIDE;
HUMANS;
HYPOGLYCEMIC AGENTS;
INJECTIONS, INTRAVENOUS;
LIPID PEROXIDES;
MALE;
MIDDLE AGED;
NITRIC OXIDE;
OXIDATIVE STRESS;
VASODILATION;
|
EID: 0036047961
PISSN: 07423071
EISSN: None
Source Type: Journal
DOI: 10.1046/j.1464-5491.2002.00762.x Document Type: Article |
Times cited : (67)
|
References (23)
|